Free Access
Med Sci (Paris)
Volume 38, Number 2, Février 2022
Page(s) 152 - 158
Section M/S Revues
Published online 18 February 2022
  1. Manu SK, Bonney JHK, Pratt D, et al. Arbovirus circulation among febrile patients at the greater Accra Regional Hospital, Ghana. BMC Res Notes 2019; 12. [PubMed] [Google Scholar]
  2. Beltrán-Silva SL, Chacón-Hernández SS, Moreno-Palacios E, et al. Clinical and differential diagnosis: Dengue, chikungunya and Zika. Revista Médica del Hospital General de México 2018 ; 81 : 146–153. [CrossRef] [Google Scholar]
  3. Gubler DJ. Dengue and Dengue Hemorrhagic Fever. CABI Publishing, 1998, 496 p. [Google Scholar]
  4. Guzman MG, Gubler DJ, Izquierdo A, et al. Dengue infection. Nat Rev Dis Primers 2016 ; 2 : 1–25. [Google Scholar]
  5. Moore DL, Causey OR, Carey DE, et al. Arthropod-borne viral infections of man in nigeria, 1964–1970. Ann Trop Med Parasitol 1975 ; 69 : 49–64. [CrossRef] [Google Scholar]
  6. Amarasinghe A, Kuritsky JN, William Letson G, et al. Dengue virus infection in Africa. Emerg Infect Dis 2011 ; 17 : 1349–1354. [PubMed] [Google Scholar]
  7. Stoler J, Dashti R al, Anto F, et al. Deconstructing “malaria”: West Africa as the next front for dengue fever surveillance and control. Acta Trop 2014; 134 : 58–65. [CrossRef] [PubMed] [Google Scholar]
  8. Perera R, Kuhn RJ. Structural proteomics of dengue virus. Curr Opin Microbiol 2008 ; 11 : 369–377. [CrossRef] [PubMed] [Google Scholar]
  9. Libraty DH, Young PR, Pickering D, et al. High Circulating Levels of the Dengue Virus Nonstructural Protein NS1 Early in Dengue Illness Correlate with the Development of Dengue Hemorrhagic Fever. J Infect Dis 2002 ; 186 : 1165–1168. [CrossRef] [PubMed] [Google Scholar]
  10. Diamond MS, Pierson TC. Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Cell 2015 ; 162 : 488–492. [CrossRef] [PubMed] [Google Scholar]
  11. Hanley KA, Monath TP, Weaver SC, et al. Fever versus fever: The role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol 2013 ; 19 : 292–311. [CrossRef] [PubMed] [Google Scholar]
  12. Guzman MG, Halstead SB, Artsob H, et al. Dengue: A continuing global threat. Nat Rev Microbiol 2010 ; 8 : S7–S16. [CrossRef] [PubMed] [Google Scholar]
  13. Wilder-Smith A, Chen LH, Massad E, et al. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis 2009 ; 15 : 8–11. [CrossRef] [PubMed] [Google Scholar]
  14. Chen LH, Wilson ME. Transmission of dengue virus without a mosquito vector: nosocomial mucocutaneous transmission and other routes of transmission. Clin Infect dis 2004 ; 39 : e56–e60. [CrossRef] [PubMed] [Google Scholar]
  15. Basurko C, Matheus S, Hildéral H, et al. Estimating the risk of vertical transmission of dengue: A prospective study. Am J Trop Med Hyg 2018 ; 98 : 1826–1832. [CrossRef] [PubMed] [Google Scholar]
  16. Perre P Van de, Molès JP, Nagot N, et al. Revisiting Koch’s postulate to determine the plausibility of viral transmission by human milk. Pediat Allergy Immunol 2021; 00 : pai.13473. [Google Scholar]
  17. Siler JF, Hall MW, Hitchens AP. Dengue: Its History, Epidemiology, Mechanism of Transmission, Etiology, Clinical Manifestations, Immunity, and Prevention. Philipp J Sci 1926; 29. [Google Scholar]
  18. Balmaseda A, Hammond SN, Pérez L, et al. Serotype-specific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006 ; 74 : 449–456. [CrossRef] [PubMed] [Google Scholar]
  19. Muller DA, Depelsenaire ACI, Young PR. Clinical and laboratory diagnosis of dengue virus infection. J Infect Dis 2017 ; 215 : S89–S95. [CrossRef] [PubMed] [Google Scholar]
  20. Mangada MM, Rothman AL. Altered Cytokine Responses of Dengue-Specific CD4 + T Cells to Heterologous Serotypes. J Immunol 2005 ; 175 : 2676–2683. [CrossRef] [PubMed] [Google Scholar]
  21. Mongkolsapaya J, Dejnirattisai W, Xu XN, et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 2003 ; 9 : 921–927. [CrossRef] [PubMed] [Google Scholar]
  22. Katzelnick LC, Narvaez C, Arguello S, et al. Zika virus infection enhances future risk of severe dengue disease. Science 2020; 369 : 1123–8. [CrossRef] [PubMed] [Google Scholar]
  23. Sierra BDLC, Kourí G, Guzmán MG. Race: A risk factor for dengue hemorrhagic fever. Arch Virol 2007 ; 152 : 533–542. [CrossRef] [PubMed] [Google Scholar]
  24. Puccioni-Sohler M, Orsini M, Soares CN. Dengue: A new challenge. Neurol Int 2012 ; 4 : 65–70. [Google Scholar]
  25. Chaturvedi UC, Dhawan R, Khanna M, et al. Breakdown of the blood-brain barrier during dengue virus infection of mice. J Gen Virol 1991 ; 72 : 859–866. [CrossRef] [PubMed] [Google Scholar]
  26. Whitehorn J, Farrar J. Dengue. Br Med Bull 2010 ; 95 : 161–173. [CrossRef] [PubMed] [Google Scholar]
  27. Franco L, di Caro A, Carletti F, et al. Recent expansion of dengue virus serotype 3 in West Africa. Eurosurveillance 2010 ; 15 : 1–4. [CrossRef] [Google Scholar]
  28. Murray NEA, Quam MB, Wilder-Smith A. Epidemiology of dengue: Past, present and future prospects. Clin Epidemiol 2013 ; 5 : 299–309. [PubMed] [Google Scholar]
  29. World Health Organization. Report of the Scientific Working Group meeting on Dengue. Geneva ; 1–5 October 2006. 2006. [Google Scholar]
  30. Ridde V, Agier I, Bonnet E, et al. Presence of three dengue serotypes in Ouagadougou (Burkina Faso): Research and public health implications. Infect Dis Poverty 2016 ; 5 : 23. [CrossRef] [PubMed] [Google Scholar]
  31. Ninove L, Parola P, Baronti C, et al. Dengue virus type 3 infection in traveler returning from West Africa. Emerg Infect Dis 2009 ; 15 : 1871–1872. [CrossRef] [PubMed] [Google Scholar]
  32. Phoutrides EK, Coulibaly MB, George CM, et al. Dengue virus seroprevalence among febrile patients in Bamako, Mali: Results of a 2006 surveillance study. Vector Borne Zoonotic Dis 2011 ; 11 : 1479–1485. [CrossRef] [PubMed] [Google Scholar]
  33. Eldin C, Gautret P, Nougairede A, et al. Identification of dengue type 2 virus in febrile travellers returning from Burkina Faso to France, related to an ongoing outbreak, October to November 2016. Eurosurveillance 2016; 21. [Google Scholar]
  34. Gulati S, Maheshwari A. Dengue fever-like illnesses: How different are they from each other?. Scand J Infect Dis 2012 ; 44 : 522–530. [CrossRef] [PubMed] [Google Scholar]
  35. Tuiskunen Bäck A, Lundkvist Å. Dengue viruses – an overview. Infect Ecol Epidemiol 2013; 3 : 19839. [Google Scholar]
  36. Sridhar S, Luedtke A, Langevin E, et al. Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med 2018 ; 379 : 327–340. [CrossRef] [PubMed] [Google Scholar]
  37. Ouédraogo S, Degroote S, Barro SA, et al. Recurrence of dengue epidemics in Burkina Faso: Community preference for an intervention to prevent the disease. Revue d’Epidemiologie et de Sante Publique 2019 ; 67 : 375–382. [CrossRef] [Google Scholar]
  38. Lim JK, Seydou Y, Carabali M, et al. Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou. Burkina Faso. PLoS Negl Trop Dis 2019 ; 13 : e0007882. [CrossRef] [Google Scholar]
  39. Onoja AB, Adeniji JA, Olaleye OD. High rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria. Acta Trop 2016 ; 160 : 39–43. [CrossRef] [PubMed] [Google Scholar]
  40. Fagbami AH, Onoja AB. Dengue haemorrhagic fever: An emerging disease in Nigeria. West Africa. J Infect Public Health 2018 ; 11 : 757–762. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.